PS in FD longitudinal study

Status: Recruiting

The Nutritional Supplement Phosphatidylserine in Patients with Familial Dysautonomia (longitudinal study): In this study, we will determine whether increasing IKAP levels with the nutritional supplement phosphatidylserine has any impact on the clinical features of the disease. We will follow patients with FD who are taking phosphatidylserine in a longitudinal observational study and follow their clinical features over time. We will pay particular attention to walking/balance and changes in the retina to determine whether phosphatidylserine can slow the progressive features of the disease.

Eligibility: The study is open to people with familial dysautonomia of any age.  

IRB#: S11-02100

Sponsor: Dysautonomia Foundation, Inc.